Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-23T15:51:57.030Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of Surveillance for Vancomycin-Resistant Enterococci on Controlling a Bloodstream Outbreak Among Patients With Hematologic Malignancy

Published online by Cambridge University Press:  02 January 2015

Ray Hachem ,
Linda Graviss ,
Hend Hanna ,
Rebecca Arbuckle ,
Tanya Dvorak ,
Brenda Hackett ,
Virginia Gonzalez ,
Cheryl Perego ,
Jeffrey Tarrand  and
Issam Raad
Ray Hachem*
Affiliation:
Department of Infectious Diseases, Houston, Texas
Linda Graviss
Affiliation:
Department of Infectious Diseases, Houston, Texas
Hend Hanna
Affiliation:
Department of Infectious Diseases, Houston, Texas
Rebecca Arbuckle
Affiliation:
Pharmacy Department, Houston, Texas
Tanya Dvorak
Affiliation:
Department of Infectious Diseases, Houston, Texas
Brenda Hackett
Affiliation:
Department of Infectious Diseases, Houston, Texas
Virginia Gonzalez
Affiliation:
Department of Infectious Diseases, Houston, Texas
Cheryl Perego
Affiliation:
Department of Infectious Diseases, Houston, Texas
Jeffrey Tarrand
Affiliation:
Department of Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Issam Raad
Affiliation:
Department of Infectious Diseases, Houston, Texas
*
Anderson Cancer Center, Department of Infectious Diseases, Unit 402, 1515 Holcombe Blvd., Houston, TX 77030
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the impact of stool surveillance cultures of critically ill patients on controlling vancomycin-resistant enterococci (VRE) outbreak bacteremia.

Design:

Stool surveillance cultures were performed on patients who had hematologic malignancy or were critically ill at the time of hospital admission to identify those colonized with VRE. Hence, contact isolation was initiated.

Setting:

A tertiary-care cancer center with a high prevalence of VRE.

Participants:

All patients with hematologic malignancy who were admitted to the hospital as well as all of those admitted to the intensive care unit were eligible.

Results:

Active stool surveillance cultures performed between 1997 and 2001 decreased the incidence density of VRE bacteremias eightfold while vancomycin use remained constant. In fiscal year (FY) 1997 and FY 1998, there were five and three VRE outbreak bacteremias, respectively. The outbreak clones were responsible for infection in 69% of those patients with VRE bacteremia. However, the stool surveillance program resulted in the complete control of VRE bacteremia by FY 1999 until the end of the study.

Conclusion:

Despite the steady use of vancomycin, the active surveillance program among high-risk patients with hematologic malignancy and those who were critically ill resulted in the complete control of VRE outbreak bacteremia at our institution.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 5 , May 2004 , pp. 391 - 394
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998;26:522–533.CrossRefGoogle Scholar
2.Edmond, MB, Ober, JF, Dawson, JD, Weinbaum, DL, Wenzel, RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234–1239.CrossRefGoogle ScholarPubMed
3.Fridkin, SK, Steward, CD, Edwards, JR, et al.Surveillance of antimicrobial use in United States hospitals: project ICARE phase 2. Clin Infect Dis 1999;29:245–252.CrossRefGoogle ScholarPubMed
4.Ostrowsky, BE, Trick, WE, Sohn, AH, et al.Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427–1433.CrossRefGoogle ScholarPubMed
5.Grayson, ML, Grabsch, EA, Johnson, PD, et al.Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust 1999;171:133–136.CrossRefGoogle Scholar
6.Hendrix, CW, Hammond, JMJ, Swoboda, SM, et al.Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients. Ann Surg 2001;233:259–265.Google Scholar
7.Price, CS, Paule, S, Noskin, GA, Peterson, LR. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003;37:921–928.Google Scholar
8.Montecalvo, MA, Jarvis, WR, Uman, J, et al.Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269–272.Google Scholar
9.National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteremia That Grow Aerobically. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993. Approved standard M7-A3.Google Scholar
10.Tenover, FC, Arbeit, RD, Goering, RV, et al.Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.Google Scholar
11.Montecalvo, MA, Shay, DK, Patel, P, et al.Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996;156:1458–1462.Google Scholar
12.Lautenbach, E, Bilker, WB, Brennan, PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999;20:318–323.CrossRefGoogle ScholarPubMed
13.Hanna, H, Umphrey, J, Tarrand, J, Mendoza, M, Raad, I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 2001;22:217–219.Google Scholar
14.Sample, ML, Gravel, D, Oxley, C, Toye, B, Garber, G, Ramotar, K. An outbreak of vancomycin-resistant enterococci in a hematology oncology unit: control by patient cohorting and terminal cleaning of the environment. Infect Control Hosp Epidemiol 2002;23:468–470.CrossRefGoogle Scholar
15.Fridkin, SK, Edwards, JR, Courval, JM, et al.The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135:175–183.Google Scholar